Display options
Share it on

World Allergy Organ J. 2008 Jun;1(6):103-13. doi: 10.1097/WOX.0b013e31817aecbe.

Angioedema.

The World Allergy Organization journal

Allen P Kaplan

Affiliations

  1. From the National Allergy, Asthma, and Urticaria Centers of Charleston, Charleston, SC.

PMID: 23282406 PMCID: PMC3651192 DOI: 10.1097/WOX.0b013e31817aecbe

Abstract

Angioedema can be caused by either mast cell degranulation or activation of the kallikrein-kinin cascade. In the former case, angioedema can be caused by allergic reactions caused by immunoglobulin E (IgE)-mediated hypersensitivity to foods or drugs that can also result in acute urticaria or a more generalized anaphylactic reaction. Nonsteroidal anti-inflammatory drugs (cyclooxygenase 1 inhibitors, in particular) may cause angioedema with or without urticaria, and leukotrienes may have a particular role as a mediator of the swelling. Reactions to contrast agents resemble allergy with basophil and mast cell degranulation in the absence of specific IgE antibody and can be generalized, that is, anaphylactoid. Angioedema accompanies chronic urticaria in 40% of patients, and approximately half have an autoimmune mechanism in which there is IgG antibody directed to the subunit of the IgE receptor (40%) or to IgE itself (5%-10%). Bradykinin is the mediator of angioedema in hereditary angioedema types I and II (C1 inhibitor [INH] deficiency) and the newly described type III disorder some of which are caused bya mutation involving factor XII. Acquired C1 INH deficiency presents in a similar fashion to the hereditary disorder and is due either toC1 INH depletion by circulating immune complexes or to an IgG antibody directed to C1 INH. Although each of these causes excessive bradykinin formation because of activation of the plasma bradykinin-forming pathway, the angioedema due to angiotensin-converting enzyme inhibitors is caused by excessive bradykinin levels due to inhibition of bradykinin degradation. Idiopathic angioedema (ie, pathogenesis unknown) may be histaminergic, that is, caused by mast cell degranulation with histamine release, or nonhistaminergic. The mediator pathways in the latter case are yet to be defined. A minority may be associated with the same autoantibodies associated with chronic urticaria. Angioedema that is likely to be life threatening (laryngeal edema or tongue/pharyngeal edema that obstructs the airway) is seen in anaphylactic/anaphylactoid reactions and the disorders mediated by bradykinin.

References

  1. J Invest Dermatol. 1996 May;106(5):1001-6 - PubMed
  2. J Clin Invest. 1995 Dec;96(6):2606-12 - PubMed
  3. Br J Dermatol. 2000 Aug;143(2):365-72 - PubMed
  4. J Allergy Clin Immunol. 2002 Apr;109(4):694-700 - PubMed
  5. Ann Intern Med. 1977 Mar;86(3):312-3 - PubMed
  6. J Allergy Clin Immunol. 2007 Jun;119(6):1497-503 - PubMed
  7. Biochem Pharmacol. 1986 Jun 15;35(12):1957-63 - PubMed
  8. Australas J Dermatol. 1992;33(1):35-8 - PubMed
  9. Br J Dermatol. 1997 Feb;136(2):153-8 - PubMed
  10. J Allergy Clin Immunol. 1999 Jul;104(1):169-72 - PubMed
  11. Mol Med. 1998 Feb;4(2):119-28 - PubMed
  12. Lancet. 2000 Jul 15;356(9225):213-7 - PubMed
  13. Br J Dermatol. 1994 Mar;130(3):381-4 - PubMed
  14. J Allergy Clin Immunol. 1986 Nov;78(5 Pt 1):914-8 - PubMed
  15. J Invest Dermatol. 1976 Jun;66(6):344-50 - PubMed
  16. Laryngoscope. 1993 Jan;103(1 Pt 1):10-2 - PubMed
  17. Am J Med Sci. 1982 Jul-Aug;284(1):2-9 - PubMed
  18. JAMA. 1997 Jul 16;278(3):232-3 - PubMed
  19. Eur J Immunol. 1971 Apr;1(2):146-9 - PubMed
  20. Intensive Care Med. 1997 Jul;23(7):793-6 - PubMed
  21. Clin Exp Allergy. 2005 Apr;35(4):456-60 - PubMed
  22. J Allergy Clin Immunol. 2005 Apr;115(4):815-21 - PubMed
  23. Intern Med. 1993 May;32(5):424-6 - PubMed
  24. Arch Dermatol. 1983 Aug;119(8):636-40 - PubMed
  25. Ann Intern Med. 1980 Sep;93(3):443-5 - PubMed
  26. J Allergy Clin Immunol. 1995 Aug;96(2):259-61 - PubMed
  27. N Engl J Med. 2002 Jan 17;346(3):175-9 - PubMed
  28. J Allergy Clin Immunol. 1983 Sep;72(3):294-8 - PubMed
  29. Clin Exp Allergy. 1997 Dec;27(12):1417-24 - PubMed
  30. Br J Dermatol. 1980 Oct;103(4):405-9 - PubMed
  31. N Engl J Med. 1996 Jun 20;334(25):1630-4 - PubMed
  32. J Allergy Clin Immunol. 1996 Apr;97(4):998-1008 - PubMed
  33. Lancet. 2000 Aug 19;356(9230):608-9 - PubMed
  34. N Engl J Med. 1993 Jun 3;328(22):1599-604 - PubMed
  35. J Clin Invest. 1989 Feb;83(2):698-707 - PubMed
  36. Annu Rev Immunol. 1999;17:931-72 - PubMed
  37. J Allergy Clin Immunol. 1998 May;101(5):672-6 - PubMed
  38. Intern Med. 1993 Apr;32(4):308-10 - PubMed
  39. Immunobiology. 1998 Aug;199(2):358-65 - PubMed
  40. J Allergy Clin Immunol. 1977 Jul;60(1):38-40 - PubMed
  41. J Allergy Clin Immunol. 2007 Feb;119(2):441-8 - PubMed
  42. Mol Pharmacol. 1984 Mar;25(2):287-93 - PubMed
  43. Clin Exp Immunol. 1996 Dec;106(3):475-80 - PubMed
  44. Clin Exp Allergy. 2005 Dec;35(12):1599-607 - PubMed
  45. J Invest Dermatol. 1988 Feb;90(2):213-7 - PubMed
  46. Int Arch Allergy Immunol. 2002 May;128(1):1-7 - PubMed
  47. Blut. 1976 Mar;32(3):195-206 - PubMed
  48. Am J Emerg Med. 1993 Jul;11(4):350-4 - PubMed
  49. J Clin Invest. 1995 Mar;95(3):1299-305 - PubMed
  50. J Allergy Clin Immunol. 2000 Apr;105(4):664-72 - PubMed
  51. Am J Gastroenterol. 1994 Jan;89(1):127-8 - PubMed
  52. J Lab Clin Med. 1969 Dec;74(6):902-10 - PubMed
  53. J Allergy Clin Immunol. 2002 Feb;109(2):349-56 - PubMed
  54. J Immunol. 1997 Jul 15;159(2):983-8 - PubMed
  55. J Clin Invest. 1983 Apr;71(4):1041-6 - PubMed
  56. J Allergy Clin Immunol. 1983 Jul;72(1):54-60 - PubMed
  57. Am J Med. 2005 Dec;118(12):1428-9 - PubMed
  58. J Allergy Clin Immunol. 1994 May;93(5):870-6 - PubMed
  59. J Exp Med. 1980 Sep 1;152(3):742-7 - PubMed
  60. N Engl J Med. 1985 Feb 28;312(9):534-40 - PubMed
  61. JAMA. 1988 Aug 19;260(7):967-70 - PubMed
  62. Clin Exp Allergy. 2007 May;37(5):631-50 - PubMed
  63. J Allergy Clin Immunol. 1989 Jul;84(1):66-71 - PubMed
  64. J Allergy Clin Immunol. 2000 Apr;105(4):776-81 - PubMed
  65. Am J Med. 1999 Jun;106(6):650-4 - PubMed
  66. N Engl J Med. 1987 May 28;316(22):1360-6 - PubMed
  67. JAMA. 1990 Sep 12;264(10):1287-9 - PubMed
  68. Am J Med. 1963 Jul;35:37-44 - PubMed
  69. J Physiol. 1967 Nov;193(2):255-67 - PubMed
  70. Biochem Pharmacol. 1986 Jun 15;35(12):1951-6 - PubMed
  71. J Allergy Clin Immunol. 2000 Sep;106(3):546-50 - PubMed
  72. Blood. 1976 Oct;48(4):567-80 - PubMed
  73. J Allergy Clin Immunol. 2006 May;117(5):1113-7 - PubMed
  74. J Clin Invest. 1993 Mar;91(3):1258-62 - PubMed
  75. Am J Med. 1976 May 31;60(6):749-59 - PubMed
  76. J Allergy Clin Immunol. 1986 May;77(5):749-57 - PubMed
  77. J Allergy Clin Immunol. 1999 Dec;104(6):1321-2 - PubMed
  78. J Clin Invest. 1976 May;57(5):1369-77 - PubMed
  79. J Allergy Clin Immunol. 2002 Feb;109(2):343-8 - PubMed
  80. Clin Pharmacol Ther. 1996 Jul;60(1):8-13 - PubMed
  81. J Allergy Clin Immunol. 1988 Jun;81(6):1199-204 - PubMed
  82. J Clin Invest. 1991 May;87(5):1614-20 - PubMed
  83. J Allergy Clin Immunol. 1978 Oct;62(4):217-21 - PubMed
  84. Nature. 1986 Oct 23-29;323(6090):722-4 - PubMed
  85. Int Arch Allergy Immunol. 2002 Nov;129(3):254-60 - PubMed
  86. Medicine (Baltimore). 1992 Jul;71(4):206-15 - PubMed
  87. Immunopharmacology. 1996 Jun;33(1-3):361-4 - PubMed
  88. J Invest Dermatol. 1983 Jul;81(1):39-43 - PubMed
  89. J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):484-93 - PubMed
  90. Lancet. 1998 Jun 6;351(9117):1693-7 - PubMed
  91. J Allergy Clin Immunol. 2004 Sep;114(3):465-74; quiz 475 - PubMed
  92. J Allergy Clin Immunol. 2002 Jan;109(1):114-8 - PubMed

Publication Types